The 21st World TCM Conference, organized by the World Federation of Chinese Medicine Societies and hosted by the France-China Traditional Chinese Medicine Center, was grandly held on October 25 at the UNESCO headquarter in Paris.

          Nanjing Ubond Pharm-tech Co., Ltd., with its globally pioneering NOS nano-silver technology, received the 'Technological Innovation' advanced unit award from the France-China Traditional Chinese Medicine Center and the World Federation of Chinese Medicine Societies for its three products in the 'Ubond Antibacterial Medical Dressing' series.

         In 2012, the World Federation of Chinese Medicine Societies(WFCMS) became a non-governmental organization certified by the UNESCO Committee for the Safeguarding of the Intangible Cultural Heritage.

        Over the years, the "World Congress of Chinese Medicine" sponsored by the World Federation of Chinese Medicine Societies has become a large-scale, widely participated and high-level academic event in the field of Chinese medicine in the world, aiming to promote the global development of Chinese medicine and promote the entry of Chinese medicine into the medical and health care systems of various countries. It has been held 21 times in Beijing, Toronto, Singapore, Melbourne, The Hague, London, San Francisco, St. Petersburg, Barcelona and other parts of the world.

        Taking the opportunity of celebrating the 60th anniversary of the establishment of diplomatic relations between China and France, this World Congress of Chinese Medicine has received strong support from the Chinese Embassy in France to "promote mutual learning between Chinese and Western civilizations and promote the global sharing of traditional Chinese medicine".

         Ms. Chen Yiwen, the founder of "Ubond", attended this event as a special guest to witness the important moment of global sharing of traditional Chinese medicine and exchanges and mutual learning with modern medicine and Western civilization.

         As a R&D and production enterprise of Ubond antibacterial medical dressings, Nanjing Showsun Pharm-tech Co., Ltd. and its brand "Ubond" have a significant industry position and influence in the medical field, especially NOS nano-silver technology, as the world's initial innovation, was the first to be applied to clinical large-scale anti-infection treatment, and has shown definite efficacy in various treatment fields such as traumatic wound infection, and its safe, effective and cost-effective advantages are at the world's leading level, and its long-acting, broad-spectrum and hydrophilic product characteristics have brought a comprehensive breakthrough of clinical significance. It has opened a new channel for NOS nano-silver technology to lead the anti-infection medical treatment of wounds.

        "Ubond" is suitable for a variety of clinical and daily needs, "large infections, small wounds" can be used, with a wide range of applicability, including diabetic ulcers, chronic ulcers, burns, pressure ulcers, post-operative wound treatment and various acute trauma, it can play an important role in daily care at home and hospital severe trauma treatment, providing one-stop solutions, significantly improving the quality of life of patients, "Ubond" remarkable advantages are especially shown in the first time of wound formation, immediately play its special role, Dramatically reduces the risk of infection. This is especially critical in traffic accidents, industrial accidents, natural disasters or other emergencies to prevent infections from occurring and to protect patients from the critical window of time in the first place.

        "Ubond" is indispensable in emergency medical relief and has demonstrated excellent functional value in many major natural disasters. The Wenchuan earthquake in 2008 and the Yushu earthquake in 2010 were indispensable to "Ubond" and became an important medical material in rescue operations.

         The disruptive and innovative role of "Ubond" is also highlighted in the hydrophilic characteristics of wet treatment, and the enhancement of the anti-infection effect when exposed to water is one of its subversive advantages. Not only does the dressing not fail when exposed to water, but because of its unique mechanism properties, it can more effectively enhance the antibacterial effect and anti-infection ability in a humid environment, which subverts the traditional cognition.

         In particular, it is worth paying attention to the significance of "Ubond" applied to diabetic ulcer wounds. According to statistics, there are about 400 million diabetic patients in the world, diabetic foot lesions are one of the most common serious complications of diabetes, and the difficult wound healing of diabetic patients is a public health problem in the world, and data shows that more than 1 million people in the world have amputations due to diabetic foot ulcer every year! In 2020, the total medical cost of diabetes in adults in China alone was 1.75 trillion yuan and increasing year by year, and the medical cost of diabetic foot ulcer was about 520 billion yuan.

         In the context of this global health problem, the importance of "Ubond" in the field of diabetic wounds has been highlighted. "Ubond" can block the early infection process of diabetic wounds, prevent and reduce the occurrence and formation of diabetic foot, and can save a lot of public medical expenses.
          Based on the above characteristics, "Ubond" has passed the registration and approval of Class III medical devices of National Medical Products Administration (NMPA), the highest level in China. It marks that "Ubond" has reached the national standards in terms of safety, effectiveness and quality control. In addition, it has also won honors including the Torch Program of the Ministry of Science and Technology of the People's Republic of China, and the "100 Projects in Ten Years" project promoted by the Ministry of Health for rural and urban communities. This not only proves the leading position of "Ubond" in technology and innovation, but also reflects its significant contribution to improving public health.